$SFLM DD - Updated December 4,

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
340
$SFLM DD - Updated December 4, 2022

Backstory

- From October 2020 to November 2022, SFLMaven Corp - ticker $SFLM [formerly $SKDI to March 2021] - comprised only the wholly owned subsidiary SFLMaven of Florida, LLC - a Top Rated eBay seller of jewelry in business for 19+ years.

- Despite SFLMaven of Florida, LLC increasing gross revenue by 35% in 2021 over 2020 - and being on track for a further 15%>20% increase in 2022, it was still operating at a net loss in 2022 Q3 after taking into account large past adjustments for eBay seller's fees in earlier backdated periods.

- In Summer 2022, $SFLM opened a Metaverse store, started to create a collection of NFT items for sale and filed a provisional patent for its "HoloGlow" technology - a ground-breaking technology that allows NFT’s to have a graphical interface that tells others the NFT has significant value [source: PR dated July 26, 2022].

"New" SFLMaven Corp [$SFLM] - Effective November 15, 2022 Onwards

On November 15, 2022, it was PR'ed that:

- Chad MacKay had been appointed as Chairman and CEO of SFLMaven Corp [replacing Joe Ladin].

- He will oversee the launch of the Company’s new business plan that focuses on acquisitions or technology licensing opportunities.

- The Company will f ocus on identifying companies and/or technologies that could be impactful in their respective industries.

- Chad MacKay is the co-founder and managing partner of Loyal Companies, a private equity firm focusing on mergers and acquisitions.

- The Company’s previous Chairman and CEO, Joseph Ladin, resigned as Chairman and CEO as part of these changes.

- SFLMaven Corp has decided to divest of its operating subsidiary, SFLMaven of Florida, LLC.

- It has not yet been stated whether the Metaverse store and/or the patent pending "HoloGlow" technology is included in the divestiture transaction.

$SFLM CEO - Chad MacKay

- Prior to joining Loyal Companies, Chad MacKay was founder and managing partner of Kai Data Companies.

- He has been actively involved as a director with other companies and organizations. Among the boards on which he serves currently and in the past are: Loyal Companies, Revvu, Cumulus, Cumulus Advanced Technologies, Kai Data, Vulcan7, Espresso Agent, Team Leads, Bear River Management Group, Kai Insurance, Synergy Holdings, RAD, Loyal Technologies, Trustee for Chase N' Heaven and Brother's Keeper.

- In the November 15, 2022 PR he stated:

- “I am very excited to become a part of SFLMaven Corp as the Company’s Chairman and CEO."

- "I have been in private equity for the past 15 years and have done a lot of exciting deals."

- "Our team has built an impressive deal flow of prospects that could be acquired or technology that could be licensed by SFLM.”

- “Our goal will be to add acquisitions and/or licensing agreements to technologies that we believe will be accretive to the Company and our Shareholders. For example, we are working with one credible University on some amazing technologies in the lithium mining industry that could be really important to the future of electric batteries."

- "Where it makes sense to focus on specific verticals, we will. If we find Companies that could benefit by being a part of the SFLM family of companies we will evaluate those.

- "We have an aggressive team and look forward providing more detailed updates in the near future.”

$SFLM CEO Linkedin Profile:

https://www.linkedin.com/in/chad-mackay-2b3417156

Loyal Companies website: https://www.loyalcompanies.com/

" New" $SFLM PRs Since November 15, 2022

Ongoing PR campaign with 1 release to date.

News - November 15. SFLMaven Corp. Announces the Appointment of Chad MacKay as Chairman and CEO and Announces New Business Plan.

https://www.otcmarkets.com/stock/SFLM/news/SF...?id=380331

Share Structure - Updated December 1, 2022

Verified Profile - updated about monthly.


Authorized Shares: 5,000,000,000 [same as in January 2020]

Outstanding Shares: 2,238,709,801 [up 56.25M - all Restricted]

Restricted: 219,001,359 [up 56.25M]

Unrestricted: 2,019,708,442 [no change]

Note: It is only the Unrestricted Outstanding Shares count that is relevant to immediate trading. This is relatively low at 2.02B for a stock in the .0010 > .25 price range.

Trading Patterns - Previous Business Model - 2021 > November 14, 2022

Note 1: Details of runs in 2019 and 2020 of up to 433% have been deleted - still available to view in the contemporaneous record here.

Note 2: Now that we are expecting runs of 1000% > 2000% in 2022/3 from current levels, details of 8 x runs less than 84% in 2021 have been deleted.

2021

Started breakout from .0038 (previous close) > .0050 on January 6, 2021

Ran from .0052 > .0064 on February 9 - 23%

Ran from .0062 > .0080 on February 10 - 29%

Ran from .0073 > .0091 on February 11 - 25%

Ran from .0070 > .0088 on February 18 - 26%

Ran from .0076 > .0091 on March 3 - 20%

Ran from .0086 (previous close) > .0197 (then new 2021 high) on March 24 - 129%

Ran from .0092 (previous close) > .0169 on March 29 on just under 99M traded - 84%

Ran from .0169 (previous close) > .0200 (new 2021 high) on March 30 - 18%

Ran from .0127 (previous close) > .0160 on April 1 on just 28M traded - 26%

Ran from .0098 (previous close ) > .0119 on April 8 - 21%

Ran from .0060 (previous close) > .0117 on July 15 - 95%

Ran from .0018 (days prior) > .0030 by December 14 - 66%

2022

Ran from .0018 > .0024 on February 4 - 33%

Ran from .0008 > .0014 by March 7+8 - 75%

Ran from .0008 (previous close ask) > .0011 on April 22 - 37.5%

Ran from .0009 (previous close ask) > .0012 on April 27 - 33%

Ran from .0007 (available previously) > .0012 on September 7 - 71%

Ran from .0005 (previous close) > .0007 on September 30 - 40%

Trading Patterns - New Business Model - November 15, 2022 Onwards

Breakout started from .0004 > .0007 on November 15 - 75%

Breakout continued from .0007 > .0010 on November 18 - 43%

Expect a dramatic move up anytime we get sufficiently large buys set across several successive asks - as happened on November 15 and November 18.

We should get past any remaining mass 1-tick flippers by .0012 and be back to a more normal few M per .0001 from .0013 > .0020 then much thinner still after that all the way to the .01>.02+ range IMO.

As with all my long-term top picks, knowing who got what where - relative to you by process of elimination - is important when deciding the ratio of shares to keep long-term vs locking in partial profits at peaks in the .01 > .02+ range - as is patience - this is a long-term play throughout 2022 into 2023.

Performance & Outlook

$SFLM will remain a top profit pick for me throughout 2022 into 2023 for self-evident reasons.

$SFLM was also my predicted and actual top profit earner in both 2021 and 2020 due to the extent and frequency of its probable short squeeze runs.

It pays to be ready at all times for surges.

Continued large profit trading opportunities are anticipated ahead throughout 2022 and future years for those who maintain a large inventory of shares at a variety of price points. Having plenty of shares - you don't need the cheapest - avoids the need to chase every time it runs.

Cancel any left over ask sell orders at close to get the maximum gap up at each open.

Expect .02+ at some point ahead in 2022/3 as the following catalysts play out:

- Closing of the divestiture transaction of subsidiary SFLMaven of Florida, LLC - along with removal of its losses from the balance sheet and addition of consideration for the sale.

- Clarification whether the Metaverse store is being retained by $SFLM.

- Clarification whether the patent pending "HoloGlow" technology is being retained by $SFLM.

- Updates on the "impressive deal flow of prospects that could be acquired or technology that could be licensed by SFLM” [source: PR November 15, 2022]

- Updates on the lithium mining initiative for batteries.

- Updates on acquisitions.

- Clarification whether uplisting to OTCQB (requiring a sustained .01 bid) or NASDAQ is still planned.

- Possible name change.

- Possible ticker change

SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading